09-Feb-17 The Philippines' Ayala Corp has bought into a medical startup, adding some disruptive technology to its fledgling healthcare operations. The investment vehicle AC Health took a minority stake in Wellbridge Health, which owns the online pharmacy MedGrocer. "The investment of AC Health into MedGrocer fits well with both our pharmacy and health tech aspirations," said Paolo Borromeo, CEO. [image: Nikkei Asian Reveiw]

03-Feb-17 The Korean government will invest KRW315.7 bn (USD276 mn) to secure original technologies for bio sectors such as new drugs, medical devices, future medical care, genomics and brain science in 2017. This includes KRW263 bn for bio-medical technology development projects. This year's budget is 31% more than last year’s. [image: Business Korea]

26-Jan-17 Verily, the Alphabet subsidiary formerly known as Google Life Sciences, has raised USD800 mn in funding from Temasek, the Singapore government investment company. "Proceeds may be used to support our growth in key strategic areas, including potential acquisitions, investment in partnerships and developing new opportunities on a global scale," according to a spokesperson for Verily. [image: Verily]

18-Jan-17 Private equity firms and hedge funds are investing heavily into China’s healthcare industry in a bet on the sector’s upbeat growth potential. Private hospitals and drug makers are among the bright spots for investors focusing on China, where rising income and an ageing population are boosting the demand for quality medical services. [image: South China Morning Post]

24-Nov-16 Korean biotech and healthcare companies are expanding their business in Japan. Macrogen recently established in Kyoto to provide a genome analysis service. Medipost set up a JV in Japan to release its stem cell therapy product Cartistem. MediTox is supplying anti-aging products in the Japanese market and Tego Science exhibited its anti-wrinkle cell therapy product TPX-105 at Bio Japan. [image: Business Korea]